+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030- Product Image
Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 3765945
Description Jump to:
The global blood testing market size is estimated to reach USD 160.50 billion by 2030, registering a CAGR of 8.83% from 2025 to 2030. The growth of the market is attributable to various factors including the growing demand for the identification of infectious agents and increased healthcare spending by government and regulatory bodies. Furthermore, the rising prevalence of infectious diseases, such as diabetes, COVID-19, and cardiovascular diseases, is anticipated to drive market growth. For instance, according to the CDC in 2022, approximately 37.3 million people were diagnosed with diabetes in the United States, accounting for 11.3 % of the population.

This increasing prevalence of diabetes creates a significant demand for blood tests, thus contributing to the growth of the market. Furthermore, technological advancement in the products used for blood testing fuels the growth of the market. The availability of portable glucose meters that enable patients to perform routine checkups conveniently and anywhere has contributed to an expansion of the market. In addition, the monitoring of diabetes is crucial prior to any surgical intervention for patients with diabetes, which further drives the demand for these products. The introduction of new products is anticipated to fuel market growth over the projection period.

For instance, in May 2022, Labcorp introduced an at-home collection kit with Labcorp OnDemand, which allows individuals to measure their hemoglobin A1c (HbA1c) levels from a small blood sample to monitor their sugar levels. Key organizations, such as the American Red Cross, the New York Blood Center, America's Blood Centers, Armed Services Blood Program, AABB, and Blood Centers of America, play a crucial role in providing information on plasma collection and delivery. The rise in blood donations is expected to further drive the demand for testing products used in pre-transplant and post-transplant procedures, thereby boosting market growth.

Blood Testing Market Report Highlights

  • The glucose testing segment held the largest revenue share in 2024. The segment growth is supported by the increasing prevalence of both type I and type II diabetes, along with the growing number of cases related to hereditary diabetes
  • Continuous advancements in technology have led to the development of innovative blood testing methods and devices. These advancements, such as point-of-care testing, wearable devices, and improved laboratory testing techniques, drive market growth.
  • North America held the largest revenue share in 2024 and is expected to maintain its position throughout the forecast period; however, Asia Pacific is expected to grow at a significant rate from 2025 to 2030
  • Key players operating are focusing on product launches and geographical expansion to maintain their presence. For instance, in March 2023, Apple made notable progress in the development of non-invasive blood glucose monitoring technology, enabling individuals with diabetes and other conditions to measure their blood glucose levels without the need for skin pricks or traditional blood testing methods
  • In June 2022, Apollo Cancer Centers, in collaboration with Datar Cancer Genetics, introduced a blood test capable of detecting early-stage breast cancers in asymptomatic individuals.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of target disease
3.2.1.2. Growing demand for point-of-care tests
3.2.1.3. Implementation of favorable government initiatives & external funding for R&D activities
3.2.1.4. Introduction of CLIA waived tests
3.2.1.5. Rising demand for early disease detection
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory and reimbursement policies
3.2.2.2. Limitations associated with blood testing
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Collection Site Business Analysis
4.1. Blood Testing Market: Collection Site Dashboard
4.2. Blood Testing Market: Collection Site Movement Analysis
4.3. Blood Testing Market by Collection Site, Revenue
4.4. Glucose Testing
4.4.1. Glucose Testing Market, 2018 - 2030 (USD Million)
4.5. A1C Testing
4.5.1. A1C Testing Market, 2018 - 2030 (USD Million)
4.6. Direct LDL Testing
4.6.1. Direct LDL Testing Market, 2018 - 2030 (USD Million)
4.7. Lipid Panel Testing
4.7.1. Lipid Panel Testing Market, 2018 - 2030 (USD Million)
4.8. Prostate Specific Antigen Testing
4.8.1. Prostate Specific Antigen Testing Market, 2018 - 2030 (USD Million)
4.9. COVID-19 Testing
4.9.1. COVID-19 Testing Market, 2018 - 2030 (USD Million)
4.10. BUN Testing
4.10.1. BUN Testing Market, 2018 - 2030 (USD Million)
4.11. Vitamin D Testing
4.11.1. Vitamin D Testing Market, 2018 - 2030 (USD Million)
4.12. Thyroid Stimulating Hormone (TSH) Testing
4.12.1. Thyroid Stimulating Hormone (TSH) Testing Market, 2018 - 2030 (USD Million)
4.13. Serum Nicotine/Cotinine Testing
4.13.1. Serum Nicotine/Cotinine Testing Market, 2018 - 2030 (USD Million)
4.14. High Sensitivity CRP Testing
4.14.1. High Sensitivity CRP Testing Market, 2018 - 2030 (USD Million)
4.15. Testosterone Testing
4.15.1. Testosterone Testing Market, 2018 - 2030 (USD Million)
4.16. ALT Testing
4.16.1. ALT Testing Market, 2018 - 2030 (USD Million)
4.17. Cortisol Testing
4.17.1. Cortisol Testing Market, 2018 - 2030 (USD Million)
4.18. Creatinine Testing
4.18.1. Creatinine Testing Market, 2018 - 2030 (USD Million)
4.19. AST Testing
4.19.1. AST Testing Market, 2018 - 2030 (USD Million)
4.20. Other Blood Tests
4.20.1. Other Blood Tests Market, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
5.1. Blood Testing Market Share By Region, 2024 & 2030
5.2. North America
5.2.1. North America Blood Testing Market, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. Key Country Dynamics
5.2.2.2. Competitive Scenario
5.2.2.3. Regulatory Framework
5.2.2.4. U.S. Blood Testing Market, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Key Country Dynamics
5.2.3.2. Competitive Scenario
5.2.3.3. Regulatory Framework
5.2.3.4. Canada Blood Testing Market, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Key Country Dynamics
5.2.4.2. Competitive Scenario
5.2.4.3. Regulatory Framework
5.2.4.4. Mexico Blood Testing Market, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Blood Testing Market, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. Key Country Dynamics
5.3.2.2. Competitive Scenario
5.3.2.3. Regulatory Framework
5.3.2.4. UK Blood Testing Market, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Framework
5.3.3.4. Germany Blood Testing Market, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Framework
5.3.4.4. France Blood Testing Market, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Key Country Dynamics
5.3.5.2. Competitive Scenario
5.3.5.3. Regulatory Framework
5.3.5.4. Italy Blood Testing Market, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Key Country Dynamics
5.3.6.2. Competitive Scenario
5.3.6.3. Regulatory Framework
5.3.6.4. Spain Blood Testing Market, 2018 - 2030 (USD Million)
5.3.7. Sweden
5.3.7.1. Key Country Dynamics
5.3.7.2. Competitive Scenario
5.3.7.3. Regulatory Framework
5.3.7.4. Sweden Blood Testing Market, 2018 - 2030 (USD Million)
5.3.8. Norway
5.3.8.1. Key Country Dynamics
5.3.8.2. Competitive Scenario
5.3.8.3. Regulatory Framework
5.3.8.4. Norway Blood Testing Market, 2018 - 2030 (USD Million)
5.3.9. Denmark
5.3.9.1. Key Country Dynamics
5.3.9.2. Competitive Scenario
5.3.9.3. Regulatory Framework
5.3.9.4. Denmark Blood Testing Market, 2018 - 2030 (USD Million)
5.3.10. Russia
5.3.10.1. Key Country Dynamics
5.3.10.2. Competitive Scenario
5.3.10.3. Regulatory Framework
5.3.10.4. Russia Blood Testing Market, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Blood Testing Market, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Framework
5.4.2.4. China Blood Testing Market, 2018 - 2030 (USD Million)
5.4.3. India
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. India Blood Testing Market, 2018 - 2030 (USD Million)
5.4.4. Japan
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. Japan Blood Testing Market, 2018 - 2030 (USD Million)
5.4.5. Thailand
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Framework
5.4.5.4. Thailand Blood Testing Market, 2018 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Framework
5.4.6.4. South Korea Blood Testing Market, 2018 - 2030 (USD Million)
5.4.7. Singapore
5.4.7.1. Key Country Dynamics
5.4.7.2. Competitive Scenario
5.4.7.3. Regulatory Framework
5.4.7.4. Singapore Blood Testing Market, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Blood Testing Market, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Brazil Blood Testing Market, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. Argentina Blood Testing Market, 2018 - 2030 (USD Million)
5.6. MEA
5.6.1. MEA Blood Testing Market, 2018 - 2030 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. Saudi Arabia Blood Testing Market, 2018 - 2030 (USD Million)
5.6.3. South Africa
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. South Africa Blood Testing Market, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. UAE Blood Testing Market, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. Kuwait Blood Testing Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2024
6.4. Company Profiles/Listing
6.4.1. Abbott
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Collection Site Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. bioMerieux
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Collection Site Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Quest Diagnostics Incorporated
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Collection Site Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Biomerica, Inc
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Collection Site Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. BD
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Collection Site Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. QIAGEN Siemens Healthineers AG
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Collection Site Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Danaher Corporation
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Collection Site Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Trinity Biotech Plc
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Collection Site Benchmarking
6.4.8.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Blood Testing Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 5 North America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 7 U.S. Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 8 Canada Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 9 Mexico Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 10 Europe Blood Testing Market, By Country, 2018 - 2030 (USD Million)
Table 11 Europe Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 12 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 13 Germany Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 14 UK Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 15 Spain Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 16 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 17 Italy Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 18 Sweden Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 19 Norway Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 20 Denmark Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 21 Asia Pacific Blood Testing Market, By Country, 2018 - 2030 (USD Million)
Table 22 Asia Pacific Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 23 Japan Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 24 China Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 25 India Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 26 South Korea Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 27 Australia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 28 Thailand Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 29 Latin America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
Table 30 Latin America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 31 Brazil Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 32 Argentina Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 33 MEA Blood Testing Market, By Country, 2018 - 2030 (USD Million)
Table 34 MEA Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 35 South Africa Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 36 Saudi Arabia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 37 UAE Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 38 Kuwait Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Blood Testing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Blood testing market: Testing type outlook and key takeaways
Fig. 15 Blood testing market: Testing type movement analysis & market share 2024 & 2030
Fig. 16 Glucose testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 A1C testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Direct LDL testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Lipid panel testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 PSA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 COVID-19 testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 BUN testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Vitamin D testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 TSH testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Serum nicotine/cotinine testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 CRP testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Testosterone testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 ALT testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Cortisol testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Creatinine testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 AST testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Other blood testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Regional Outlook, 2024 & 2030
Fig. 34 Regional Market Dashboard
Fig. 35 Regional Market Place: Key Takeaways
Fig. 36 North America, SWOT Analysis
Fig. 37 Europe, SWOT Analysis
Fig. 38 Asia Pacific, SWOT Analysis
Fig. 39 Latin America, SWOT Analysis
Fig. 40 MEA, SWOT Analysis
Fig. 41 North America
Fig. 42 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 43 U.S.
Fig. 44 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 45 Canada
Fig. 46 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 47 Mexico
Fig. 48 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 49 Europe
Fig. 50 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 51 UK
Fig. 52 UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 53 Germany
Fig. 54 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 55 Italy
Fig. 56 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 57 France
Fig. 58 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 59 Spain
Fig. 60 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 61 Sweden
Fig. 62 Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 63 Norway
Fig. 64 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 65 Denmark
Fig. 66 Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 67 Asia Pacific
Fig. 68 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 69 China
Fig. 70 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 71 India
Fig. 72 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 73 Japan
Fig. 74 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 75 Australia
Fig. 76 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 77 Thailand
Fig. 78 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 79 South Korea
Fig. 80 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 81 Latin America
Fig. 82 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 83 Brazil
Fig. 84 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 85 Argentina
Fig. 86 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 87 MEA
Fig. 88 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 89 UAE
Fig. 90 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 91 South Africa
Fig. 92 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 93 Saudi Arabia
Fig. 94 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 95 Kuwait
Fig. 96 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
Fig. 97 Strategy Mapping

Companies Mentioned

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • bioMerieux
  • Quest Diagnostics Incorporated
  • Biomerica
  • BD
  • Siemens Healthineers AG
  • Danaher Corporation
  • Trinity Biotech Plc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 96.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 160.5 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Blood Testing Market by Product, Test Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Blood Testing Market by Product, Test Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Blood Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Image

Blood Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • 115 Pages
  • Global
From
Home Blood Testing Devices Market Report and Forecast 2024-2032 - Product Image

Home Blood Testing Devices Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Home Blood Testing Devices Market 2024-2028 - Product Image

Home Blood Testing Devices Market 2024-2028

  • Report
  • 206 Pages
  • Global
From
2024 Global Occult Blood Testing Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities - Product Image

2024 Global Occult Blood Testing Market: US, Europe, Japan - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities

  • Report
  • 243 Pages
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.